Visual prognosis better in eyes with less severe reduction of visual acuity one year after onset of Leber hereditary optic neuropathy caused by the 11,778 mutation.
Mashima, Yukihiko
Visual prognosis better in eyes with less severe reduction of visual acuity one year after onset of Leber hereditary optic neuropathy caused by the 11,778 mutation. [electronic resource] - BMC ophthalmology Oct 2017 - 192 p. digital
Publication Type: Journal Article
1471-2415
10.1186/s12886-017-0583-3 doi
Adolescent
Adult
Age of Onset
Aged
Antioxidants--therapeutic use
Ascorbic Acid--therapeutic use
Child
DNA Mutational Analysis
DNA, Mitochondrial--genetics
Female
Follow-Up Studies
Humans
Male
Middle Aged
Optic Atrophy, Hereditary, Leber--drug therapy
Point Mutation
Polymerase Chain Reaction
Prognosis
Recovery of Function--physiology
Retrospective Studies
Riboflavin--therapeutic use
Ubiquinone--analogs & derivatives
Vision Disorders--drug therapy
Visual Acuity--physiology
Visual Field Tests
Vitamin B Complex--therapeutic use
Young Adult
Visual prognosis better in eyes with less severe reduction of visual acuity one year after onset of Leber hereditary optic neuropathy caused by the 11,778 mutation. [electronic resource] - BMC ophthalmology Oct 2017 - 192 p. digital
Publication Type: Journal Article
1471-2415
10.1186/s12886-017-0583-3 doi
Adolescent
Adult
Age of Onset
Aged
Antioxidants--therapeutic use
Ascorbic Acid--therapeutic use
Child
DNA Mutational Analysis
DNA, Mitochondrial--genetics
Female
Follow-Up Studies
Humans
Male
Middle Aged
Optic Atrophy, Hereditary, Leber--drug therapy
Point Mutation
Polymerase Chain Reaction
Prognosis
Recovery of Function--physiology
Retrospective Studies
Riboflavin--therapeutic use
Ubiquinone--analogs & derivatives
Vision Disorders--drug therapy
Visual Acuity--physiology
Visual Field Tests
Vitamin B Complex--therapeutic use
Young Adult